Webinars

KRAS G12C Mutation: An Emerging Biomarker for NSCLC

Presentation

Chapters

Video

About this Webinar

Date: Monday, January 04, 2021

Author: Fesko, Yuri, MD
Chief Clinical Officer, Oncology Quest Diagnostics
Secaucus, New Jersey

  
Also by this Author ▸

Author: Hooper, Kari, MD
Pathologist, AmeriPath®/Quest Diagnostics; Department Chair,
Integris Baptist Medical Center Oklahoma City, Oklahoma
  
Also by this Author ▸

Category: Webinar

Description: Presented by Yuri Fesko, MD and Kari Hooper, MD.

Related Content

Presentation:
Next-Generation Immunohistochemistry: A Window onto the Molecular Alterations in Tumors
Gown, Allen M., MD

Presentation:
Biomarker Testing as a Preventive Health Strategy
Fusco, Liz, MS, RDN Pryor, Luke, PhD, ATC, CSCS